When used, it should be restricted to women with all of the following criteria: invasive cancer, aged > 70 years, tumor < 2 cm, resection margins > 2 mm, grade 1–2, pN0, ER positive, HER2 negative, L0, V0, and EIC negative [23]. Here, ERBB2 is linked to neoplasm.